SYNAGEVA BIOPHARMA CORP's ticker is GEVA and the CUSIP is 87159A103. A total of 84 filers reported holding SYNAGEVA BIOPHARMA CORP in Q4 2013. The put-call ratio across all filers is 0.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2015 | $1,555,000 | -67.5% | 15,957 | -69.1% | 0.00% | -66.7% |
| Q4 2014 | $4,791,000 | +121.5% | 51,640 | +64.1% | 0.00% | +200.0% |
| Q3 2014 | $2,163,000 | +117.0% | 31,461 | +230.7% | 0.00% | 0.0% |
| Q2 2014 | $997,000 | -71.4% | 9,514 | -77.5% | 0.00% | -50.0% |
| Q1 2014 | $3,490,000 | +53.5% | 42,275 | +20.3% | 0.00% | 0.0% |
| Q4 2013 | $2,274,000 | -15.8% | 35,153 | -17.6% | 0.00% | 0.0% |
| Q3 2013 | $2,700,000 | – | 42,647 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 10,660,432 | $1,117,213,000 | 13.68% |
| BB BIOTECH AG | 898,476 | $94,160,000 | 4.47% |
| SECTORAL ASSET MANAGEMENT INC | 516,445 | $54,123,000 | 2.29% |
| Ghost Tree Capital, LLC | 30,000 | $3,144,000 | 2.22% |
| COLUMBIA WANGER ASSET MANAGEMENT LLC | 3,521,000 | $369,001,000 | 1.48% |
| Pier Capital, LLC | 83,493 | $8,750,000 | 1.24% |
| ArrowMark Colorado Holdings LLC | 197,613 | $20,710,000 | 0.59% |
| PALISADE CAPITAL MANAGEMENT, LP | 120,779 | $12,658,000 | 0.31% |
| FORTALEZA ASSET MANAGEMENT INC/ | 5,440 | $570,000 | 0.26% |
| Tradeworx Inc. | 2,936 | $308,000 | 0.25% |